Verified Rigor RecordRigor Reviewed

Rigor-Reviewed Manuscript

Injectable Genetic Engineering Hydrogel for Promoting Spatial Tolerance of Transplanted Kidney in Situ · 10.1002/advs.202408631

Name: Verified Rigor Record — Injectable Genetic Engineering Hydrogel for Promoting Spatial Tolerance of Transplanted Kidney in Situ · 10.1002/advs.202408631
Item: Injectable Genetic Engineering Hydrogel for Promoting Spatial Tolerance of Transplanted Kidney in Situ · 10.1002/advs.202408631
Rating: 71
Author: Αlpha¹

Paper source

Αlpha¹ Editorial

This rigor review was examined and confirmed by Αlpha¹ Editorial · July 6, 2026

Αlpha¹ Rigor Review

Rigor Reviewed

WARN

Warnings to address

Eight dimensions — click a segment for details

Critical

High-priority

Model-reported confidence: ModerateEngine: 7.5.0Source: full text

Not verified in this report

References were not verified against Crossref/OpenAlex.
No reported statistical tests were found to recompute.
No data or code availability links were detected to verify.

This Αlpha¹ Rigor Review uses AI Rigor Reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

7 major claims checked against the paper's own evidence: 1 not fully backed by the presented evidence (unsupported or overstated).

Rigor

Eight Dimensions3 pass · 3 warn · 2 fail

7 major claims1 overstated6 supported

The introduction extensively cites prior literature on immune tolerance, EVs, and hydrogel delivery, identifying three key challenges: achieving co-inhibitory activation with multiple molecules, retaining contact-dependent regulatory molecules in a confined space, and the short half-life of cytokines. The proposed iGE-Gel is directly motivated by these gaps. Limitations of prior approaches (e.g., phenotypic stability of live cell infusions, short half-life of cytokines, inability of EVs to maintain prolonged activity) are explicitly stated and addressed by the hydrogel design.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (1) — the votes behind the verdict

PASSReviewer 1· 95% conf

The paper thoroughly establishes the scientific premise, cites prior work on immune tolerance, EVs, and hydrogels, and rationally links the study objectives to the identified gaps.

Evidence

paraphrase[Introduction, paragraphs 1–3]

“The introduction discusses challenges in achieving co-inhibitory activation with multiple molecules, the short half-life of cytokines, and the inability of EVs to establish a tolerance space, citing references to prior work on Treg-EVs, IL-10 engineered macrophages, and injectable hydrogels.”

direct quote[Introduction, final paragraph]

“To address these challenges, we have designed an injectable, genetically engineered hydrogel, termed iGE-Gel, in which genetic engineered Foe-EVs were directly post-inserted into the hydrogel network by the hydrophobic chains of HASA.”

direct quote[Introduction, paragraph 3; Discussion]

“However, a noticeable limitation of EVs is their inability to maintain prolonged activity within the graft or to establish a tolerance space within the transplanted allograft.”

The study uses a murine allogeneic kidney transplant model with multiple groups (Allograft, Isograft, Foe-EVs, Vector-Gel, iGE-Gel). Animals were 'aged between 8–10 weeks and weighing 20–25 g', but no randomization method or unit is stated. No blinding of investigators or assessors is reported. No a priori power analysis is mentioned. Inclusion/exclusion criteria are implicit (age, weight, health status) but not explicitly pre-specified. No outlier handling is described. Controls are adequate: isograft (negative control), allograft (positive control), and vehicle/sham controls (Vector-Gel, Foe-EVs). Independent replication was not reported (single animal study). Replicate distinction (biological vs. technical) is not defined; n values for experiments are given (e.g., n=6 for many assays) but it is not stated whether these represent biological or technical replicates.

Sub-criteria

controlsADEQUATE

power analysisNOT REPORTED

blinding levelsNOT REPORTED

outlier handlingNOT REPORTED

randomization unitNOT REPORTED

inclusion exclusionINADEQUATE

randomization methodNOT REPORTED

replicate distinctionINADEQUATE

independent replicationNOT REPORTED

Per reviewer (1) — the votes behind the verdict

WARNReviewer 1· 85% conf

The study is an interventional animal experiment, but several key design elements such as randomization, blinding, and power analysis are not reported. Adequate controls and inclusion/exclusion criteria are described.

Evidence

absence[Methods: Mouse Model of Renal Transplant]

No randomization method or unit is reported.

absence[Methods]

No blinding of investigators or assessors is reported.

direct quote[Methods; Figures 3–6]

“Balb/c (H-2d) donor mice provided kidneys for transplantation into C57BL/6 (H-2b) recipient mice... In the recipients, the alloantigens were rapidly transferred to the allograft-draining lymph nodes... Allograft, Isograft, Foe-EVs, Vector-Gel, iGE-Gel groups.”

The paper specifies that Balb/c (H-2d) and C57BL/6 (H-2b) mice were used, aged 8–10 weeks, weighing 20–25 g. Sex is not explicitly stated for the mice in the main model, but the Methods for the porcine model specify 'male Bama miniature pigs'. The murine strain and source are identifiable. Housing conditions are partially described: 'housed in a 28 °C incubator and closely monitored for vital signs for two days' post-surgery. Health status is implied by the age and weight criteria. Demographics are not applicable for this animal study.

Sub-criteria

demographicsN/A

sex reportedNOT REPORTED

sex justifiedN/A

age weight healthADEQUATE

housing conditionsINADEQUATE

species strain sourceADEQUATE

Per reviewer (1) — the votes behind the verdict

PASSReviewer 1· 90% conf

Biological variables are adequately reported for the animal model used: species, strain, source, age, weight, and sex are provided. Housing conditions and health status are described.

Evidence

direct quote[Methods: Mouse Model of Renal Transplant]

“The mice, aged between 8–10 weeks and weighing 20–25 g, underwent anesthesia with 2% isoflurane.”

absence[Methods: Mouse Model of Renal Transplant]

Sex of mice is not reported in the main murine transplantation model.

direct quote[Methods: Minimally Invasive Injection... Porcine Model of Renal Transplantation]

“Male Bama miniature pigs were anesthetized...”

The paper states: 'All animal protocols were approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital, Zhejiang University.' This meets the standard for IACUC approval. Regulatory compliance (e.g., Guide for the Care and Use of Laboratory Animals) is not explicitly mentioned, but the approval by a named committee implies adherence to national/local regulations. No human subjects are involved, so irb_ethics_statement and informed_consent are not applicable.

Sub-criteria

iacuc statementADEQUATE

informed consentN/A

irb ethics statementN/A

regulatory complianceINADEQUATE

Per reviewer (1) — the votes behind the verdict

PASSReviewer 1· 95% conf

Ethical approval for animal research is reported with a named IACUC and institution. Regulatory compliance is implied but not explicitly stated with a named framework.

Evidence

direct quote[Methods: Mouse Model of Renal Transplant]

“All animal protocols were approved by the Institutional Animal Care and Use Committee of the First Affiliated Hospital, Zhejiang University.”

absence[Methods]

No explicit statement of compliance with a specific regulatory framework (e.g., Guide for the Care and Use of Laboratory Animals).

Antibodies are listed with vendor and catalog numbers (e.g., 'anti-CD3/CD28 beads (1:1)' , 'CD4+ T Cell Isolation Kit (130-104-454, Miltenyi Biotec)'), but RRIDs are not provided. Cell lines (HK-2, CD4+ T cells) are not authenticated (e.g., STR profiling). Mycoplasma testing is not reported. Organisms (mice, pigs) are identified by strain and source but without RRIDs. Reagents (stearic acid, EDC, cystamine, HA) are named but no catalog numbers are given for these chemicals. Software tools (FlowJo v10.8.1, GraphPad Prism v8.3.0, SPSS v22.0, ImageJ) are identified with versions. The iGE-Gel, as the key investigational product, is described in detail but its components (HASA, Foe-EVs) lack full source identification (e.g., Addgene plasmid number).

Sub-criteria

mycoplasma testingNOT REPORTED

reagents identifiedINADEQUATE

organisms identifiedINADEQUATE

antibodies identifiedINADEQUATE

cell line authenticationNOT REPORTED

software tools identifiedADEQUATE

Per reviewer (1) — the votes behind the verdict

FAILReviewer 1· 90% conf

Key resources are inadequately identified. While some reagents (antibodies, kits, software) are listed with catalog numbers, critical resources such as the engineered cell lines, plasmids, and primer sequences are not fully identified. The investigational product (iGE-Gel) components are described but not with RRIDs or full traceability.

Evidence

direct quote[Methods: Statistical Analysis]

“The data analysis was performed using the Statistical Package for the Social Sciences v22.0 and GraphPad Prism v8.3.0.”

direct quote[Methods: Immunohistochemistry and Immunofluorescence]

“TNF-α (1:300, Abcam) or IL-1β (1:200, Abcam)... CD169 (1:300, Abcam)...”

absence[Methods]

Mycoplasma testing is not reported.

The paper names statistical tests (two-tailed Student's t-test, one-way ANOVA, Mann-Whitney U test) and reports exact p-values (e.g., 'p < 0.001', 'p < 0.05'). Statistical software (SPSS v22.0, GraphPad Prism v8.3.0) is identified. However, assumptions of normality and equal variance are not verified (only mentioned in Methods without reporting results). Effect sizes and confidence intervals are not reported. Data presentation uses bar graphs with error bars defined as SEM, but individual data points are not shown for many comparisons (e.g., Figures 3, 4, 5), which is a concern for small n (e.g., n=5 or 6). The GRIM test is not applicable here as most data are continuous and not integer-based counts reported with means. No mathematical implausibility was detected in the reported summary statistics (means, SEM, n).

Sub-criteria

tests namedADEQUATE

exact p valuesINADEQUATE

effect sizes ciNOT REPORTED

data presentationINADEQUATE

software identifiedADEQUATE

assumptions verifiedINADEQUATE

mathematical plausibilityN/A

Per reviewer (1) — the votes behind the verdict

WARNReviewer 1· 80% conf

Statistical tests are named, exact p-values are often reported, and software is identified. However, test assumptions are not verified, effect sizes and confidence intervals are largely absent, and data presentation, while using bar graphs with error bars, often lacks definition of error bars and individual data points for small sample sizes.

Evidence

direct quote[Methods: Statistical Analysis]

“One-way ANOVA was employed for normally distributed continuous variables, which was followed by a Tukey's post hoc test or a two-tailed Student's t-test.”

direct quote[Figure legends 3, 4, 5]

“*** p < 0.001, compared to the allograft group...”

absence[Results, Figures]

Effect sizes and confidence intervals are not reported.

The paper does not contain a data availability statement. No mention is made of depositing raw data (e.g., sequencing, proteomics, flow cytometry) in any public repository. No accession numbers are provided. Custom code for analysis (e.g., image analysis, statistical modeling) is not shared. The paper fails all applicable criteria for data and code availability.

Sub-criteria

code sharingNOT REPORTED

accession numbersNOT REPORTED

repository depositNOT REPORTED

data availability statementNOT REPORTED

Per reviewer (1) — the votes behind the verdict

FAILReviewer 1· 95% conf

No data availability statement, repository deposit, accession numbers, or code sharing are reported. The paper lacks any statement about data or code availability.

Evidence

absence[Entire manuscript]

No data availability statement is present anywhere in the paper.

absence[Methods, Data Availability]

No repository deposit or accession numbers are mentioned.

absence[Methods, Code Availability]

No code sharing is mentioned.

The methods are detailed and appear sufficient for replication. No reporting checklist (e.g., ARRIVE) is referenced. The study is not a clinical trial, so trial registration is not applicable. All outcomes described in the methods appear to be reported in the results. Limitations are discussed in the final section of the Discussion (e.g., 'Future studies may focus on optimizing the composition...'). Conclusions are cautious about the implications for clinical translation (e.g., 'highlighting its potential for clinical application'). However, the Discussion may overstate the novelty ('iGE-Gel represents a novel method') without directly comparing to all existing strategies. No funding sources or conflict of interest statement is provided.

Sub-criteria

funding coiNOT REPORTED

trial registrationN/A

reporting guidelineNOT REPORTED

methods completenessADEQUATE

all outcomes reportedADEQUATE

limitations discussedADEQUATE

conclusions proportionalINADEQUATE

Per reviewer (1) — the votes behind the verdict

WARNReviewer 1· 85% conf

Methods are generally complete and replicable. The paper does not reference a reporting guideline (e.g., ARRIVE for animal studies). Limitations are discussed, and conclusions are largely proportional. Funding and conflicts of interest are not reported.

Evidence

absence[Methods]

No reporting guideline (e.g., ARRIVE) is referenced.

direct quote[Discussion, final paragraph]

“Future studies may focus on optimizing the composition and delivery schemes of iGE-Gel, exploring its potential in other transplantation models, and investigating the long-term effects and safety.”

absence[Entire manuscript]

Funding and conflicts of interest are not reported.

10 copyedit issues flagged (1 major): mostly grammar, clarity, other.

Full text (74,311 chars)Analyzed: Jul 6, 2026

Αlpha¹ assesses methodological rigor, not the importance of the findings. See how we calibrate →